Biotherapeutics
Biotherapeutics like monoclonal antibodies are crucial for treating diseases but remain inaccessible in many low- and middle-income countries. MPP is working on improving access through voluntary licensing, technology transfer, and collaborations with key stakeholders.
Local and Regional Manufacturing
MPP supports diversified manufacturing through licensing and facilitating technology transfer to local and regional manufacturers, contributing to improved access to health products, supply security, and emergency preparedness and response.
Pandemic Preparedness and Response
MPP aims to incorporate licensing and technology transfer as essential elements in the global framework for pandemic preparedness and response.
Upstream Access
MPP collaborates closely with key partners to ensure that licensing and funding agreements for early-stage health technologies include terms that facilitate access in low- and middle-income countries.
